SIS
CORT icon

Strategic Investment Solutions’s Corcept Therapeutics CORT Stock Holding History

Strategic Investment Solutions’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$11.4K – 612
2025
Q1 		$11.4K Hold
100
– – ﹤0.01% 348
2024
Q4 		$5.04K Hold
100
– – ﹤0.01% 454
2024
Q3 		$4.63K Hold
100
– – ﹤0.01% 437
2024
Q2 		$3.87K Buy
+100
New +$2.74K ﹤0.01% 446

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Strategic Investment Solutions's CORT Position: Q2 2025 in Review

Strategic Investment Solutions sold out of Corcept Therapeutics (CORT) in Q2 2025, closing a stake of 100 shares — an estimated $11.4K sold.

Strategic Investment Solutions first reported a position in CORT in Q2 2024 and held it in 4 quarters. The position peaked at $11.4K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2025.

  • Strategic Investment Solutions reported no remaining Corcept Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Strategic Investment Solutions sold 100 Corcept Therapeutics shares in Q2 2025, an estimated $11.4K.
  • Strategic Investment Solutions first reported a position in Corcept Therapeutics in Q2 2024 and held it in 4 quarters.
  • Strategic Investment Solutions's Corcept Therapeutics position peaked at $11.4K in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2025.

Based on Strategic Investment Solutions's 13F filing for Q2 2025, filed 16 Jul 2025.